Showing 381-390 of 18069 results for "".
The SEARCH for Diabetes in Asian and Pacific-Islander Youth
https://reachmd.com/programs/diabetes-discourse/the-search-for-diabetes-in-asian-and-pacific-islander-youth/5295/The estimated prevalence and incidence of diabetes for Asian and Pacific-Islander youth is growing at an incremental rate. These populations present unique challenges in both diagnosis and treatment. Join host Dr. Steven Edelman and his guest, professor emeritus of internal medicine at the UniversitGestational Diabetes--Treatment Works!
https://reachmd.com/programs/clinicians-roundtable/gestational-diabetes-treatment-works/1794/The list of maternal and neonatal morbidity from gestational diabetes is oppressive. Yet there is good evidence that aggressive glucose control can result in healthy outcomes that rival those of non-diabetic pregnancies. Our guest today is Doctor Thomas Moore. He is Professor and Chairman ofDiabetic Kidney Disease Prevention
https://reachmd.com/programs/clinicians-roundtable/diabetic-kidney-disease-prevention/329/Dr. Lori Laffel, chief of the Pediatric and Adolescent Section at Joslin Clinic and an Investigator in the section on Genetics and Epidemiology at Joslin Diabetes Center as well as an Associate Professor of Pediatrics at Harvard Medical School discusses the prevention of kidney disease in patients wThe Value of Behavior Change in Diabetes, for Patients and Professionals
https://reachmd.com/programs/diabetes-discourse/the-value-of-behavior-change-in-diabetes-for-patients-and-professionals/6261/Methods of positive behavioral change for people living with diabetes is vital to the overall management of diabetes. What is the value of behavior change for people living with diabetes and their professional counterparts? Join host Dr. Steven Edelman and his guest, professor of pediatrics and publExploring Precision Medicine in the Treatment of Diabetes
https://reachmd.com/programs/diabetes-discourse/exploring-precision-medicine-in-the-treatment-of-diabetes/14210/What would precision medicine in treating diabetes look like when applied to clinical practice? Find out more.Injectable Medication as an Alternative Treatment for Diabetic Eye Disease
https://reachmd.com/programs/the-jama-report/injectable-medication-alternative-treatment-diabetic-eye-disease/7767/[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the proceThe Benefits of Physical Therapy for Patients With Diabetes
https://reachmd.com/programs/diabetes-discourse/the-benefits-of-physical-therapy-for-patients-with-diabetes/5677/It is well established that exercise is a critical component in the management of diabetes, but many diabetes patients struggle with exercise. Physical therapists are the "exercise experts" in the guidance of patients' overall care. What are the benefits of physical therapy for patients living withTreatment Modalities for Diabetic Retinopathy
https://reachmd.com/programs/revealing-retina/treatment-modalities-for-diabetic-retinopathy/5626/The standard treatment for proliferative and non-proliferative diabetic retinopathy is laser photocoagulation, but novel methods, including injectable steroids or anti-vascular endothelial growth factor, are also showing promise. What tests can help opthamologists determine the area of leakage in thEffects of aldose reductase inhibitor on exercise capacity in diabetic cardiomyopathy
https://reachmd.com/programs/acc-action-center/effects-of-aldose-reductase-inhibitor-on-exercise-capacity-in-diabetic-cardiomyopathy/24360/ACC.24 - Can treatment with the selective aldose reductase inhibitor AT-001 prevent deterioration of exercise capacity and the onset of HF in patients with diabetic cardiomyopathy? James Januzzi shares the results of ARISE-HF.Keys to Reversing Pediatric Non-Alcoholic Fatty Liver Disease
https://reachmd.com/programs/lipid-luminations/keys-to-reversing-pediatric-non-alcoholic-fatty-liver-disease/4296/Non-alcoholic fatty liver disease (NAFLD) is increasingly common among our young obese patients, a population for which cardiovascular disease and diabetes is a significant concern. Can measured levels of liver fat serve to help us gauge future risk for metabolic consequences in children? Host Dr. L